Intravenous iron replacement agent

5 marketed 2 in Phase 3

This page covers all Intravenous iron replacement agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Iron (Fe3+) for hemoglobin synthesis and erythropoiesis, Iron(III) ion; transferrin and ferritin (iron-binding proteins), Iron (Fe³⁺) delivery; transferrin and ferritin binding.

Targets

Iron (Fe3+) for hemoglobin synthesis and erythropoiesis · Iron(III) ion; transferrin and ferritin (iron-binding proteins) · Iron (Fe³⁺) delivery; transferrin and ferritin binding · Iron (Fe³⁺) delivery system; transferrin receptor-mediated uptake · Iron (Fe3+) delivery system · Iron (Fe3+) delivery via transferrin-mediated uptake

Marketed (5)

Phase 3 pipeline (2)